These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3090143)

  • 1. Identification of an early activation antigen (Bac-1) on human B cells.
    Suzuki T; Sanders SK; Butler JL; Gartland GL; Komiyama K; Cooper MD
    J Immunol; 1986 Aug; 137(4):1208-13. PubMed ID: 3090143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new antigen identified by the monoclonal antibody UCHB 1 delivers a costimulatory signal to a subset of human B cells.
    Armitage RJ; Rowe DJ; Beverly PC
    Eur J Immunol; 1988 Jan; 18(1):67-76. PubMed ID: 3257923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
    Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
    J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 Mar; 134(3):1539-44. PubMed ID: 3918104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
    Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
    J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B5, a new B cell-restricted activation antigen.
    Freedman AS; Boyd AW; Anderson KC; Fisher DC; Schlossman SF; Nadler LM
    J Immunol; 1985 Apr; 134(4):2228-35. PubMed ID: 2579134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7, a B-cell-restricted antigen that identifies preactivated B cells.
    Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
    J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
    Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
    J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
    Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
    J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
    Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
    Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
    Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
    J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface marker expression of human B-cell lymphomas.
    Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
    AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three distinct antigen systems on human B cell subpopulations as defined by monoclonal antibodies.
    Takami T; Ishii Y; Yuasa H; Kikuchi K
    J Immunol; 1985 Feb; 134(2):828-34. PubMed ID: 3917477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
    Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
    J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel human B cell activation antigen involved in B cell growth factor-dependent proliferation.
    Tseng CT; Springgate CF; Tadmori W; Choi YS
    J Immunol; 1988 Apr; 140(7):2305-11. PubMed ID: 2450917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.